144 related articles for article (PubMed ID: 8615097)
41. [NSAIDs combined with radiotherapy to prevent heterotopic ossification after total hip arthroplasty].
Wu FF; Gao HL; Huang S; Wang GR; Jiang XS; Li JY; Shou ZQ
Zhongguo Gu Shang; 2018 Jun; 31(6):538-542. PubMed ID: 29945410
[TBL] [Abstract][Full Text] [Related]
42. Pharmacological treatment of heterotopic ossification following hip and acetabular surgery.
Macfarlane RJ; Ng BH; Gamie Z; El Masry MA; Velonis S; Schizas C; Tsiridis E
Expert Opin Pharmacother; 2008 Apr; 9(5):767-86. PubMed ID: 18345954
[TBL] [Abstract][Full Text] [Related]
43. Etiology and treatment of periarticular heterotopic ossification after total hip replacement.
Sodemann B; Persson PE; Nilsson O
Rev Chir Orthop Reparatrice Appar Mot; 1988; 74 Suppl 2():329-30. PubMed ID: 3148171
[No Abstract] [Full Text] [Related]
44. Lornoxicam in extracorporeal shock-wave lithotripsy; comparison with tenoxicam and placebo in terms of analgesic consumption.
Bilir A; Gulec S; Turgut M; Cetinkaya D; Erkan A; Kurt I
Scand J Urol Nephrol; 2008; 42(2):143-7. PubMed ID: 17853036
[TBL] [Abstract][Full Text] [Related]
45. Heterotopic bone formation following hip arthroplasty. A retrospective study of 65 bilateral cases.
Kjaersgaard-Andersen P; Steinke MS; Hougaard K; Søjbjerg JO; Jensen J
Acta Orthop Scand; 1991 Jun; 62(3):223-5. PubMed ID: 1904182
[TBL] [Abstract][Full Text] [Related]
46. Ro 12-0068 (tenoxicam) in the treatment of extra-articular inflammatory processes.
Fiszman P; Perpétuo JB; Sidi A
Eur J Rheumatol Inflamm; 1985; 8(1):15-20. PubMed ID: 3915883
[TBL] [Abstract][Full Text] [Related]
47. Heterotopic bone formation prevented by diclofenac. Prospective study of 100 hip arthroplasties.
Wahlström O; Risto O; Djerf K; Hammerby S
Acta Orthop Scand; 1991 Oct; 62(5):419-21. PubMed ID: 1950483
[TBL] [Abstract][Full Text] [Related]
48. The suppression of heterotopic ossifications: radiation versus NSAID therapy--a prospective study.
Sell S; Willms R; Jany R; Esenwein S; Gaissmaier C; Martini F; Bruhn G; Burkhardsmaier F; Bamberg M; Küsswetter W
J Arthroplasty; 1998 Dec; 13(8):854-9. PubMed ID: 9880175
[TBL] [Abstract][Full Text] [Related]
49. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty.
Romanò CL; Duci D; Romanò D; Mazza M; Meani E
J Arthroplasty; 2004 Jan; 19(1):14-8. PubMed ID: 14716644
[TBL] [Abstract][Full Text] [Related]
50. [Prevention of periarticular ossification following endoprosthetic hip replacement using postoperative irradiation].
Sauer R; Seegenschmiedt MH; Goldmann A; Beck H; Andreas P
Strahlenther Onkol; 1992 Feb; 168(2):89-99. PubMed ID: 1542851
[TBL] [Abstract][Full Text] [Related]
51. Differential analgesic effect of tenoxicam on post-cesarean uterine cramping pain between primiparous and multiparous women.
Yeh YC; Chen SY; Lin CJ; Yeh HM; Sun WZ
J Formos Med Assoc; 2005 Sep; 104(9):647-51. PubMed ID: 16276439
[TBL] [Abstract][Full Text] [Related]
52. Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac.
Winkler S; Springorum HR; Vaitl T; Handel M; Barta S; Kehl V; Craiovan B; Grifka J
Int Orthop; 2016 Apr; 40(4):673-80. PubMed ID: 26728611
[TBL] [Abstract][Full Text] [Related]
53. The analgesic efficacy of tenoxicam versus placebo in day case laparoscopy: a randomised parallel double-blind trial.
Windsor A; McDonald P; Mumtaz T; Millar JM
Anaesthesia; 1996 Nov; 51(11):1066-9. PubMed ID: 8943604
[TBL] [Abstract][Full Text] [Related]
54. Heterotopic ossification following total hip arthroplasty: a review.
Hu HP; Slooff TJ; van Horn JR
Acta Orthop Belg; 1991; 57(2):169-82. PubMed ID: 1908171
[TBL] [Abstract][Full Text] [Related]
55. Randomized trial comparing early postoperative irradiation vs. the use of nonsteroidal antiinflammatory drugs for prevention of heterotopic ossification following prosthetic total hip replacement.
Kölbl O; Knelles D; Barthel T; Kraus U; Flentje M; Eulert J
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):961-6. PubMed ID: 9392532
[TBL] [Abstract][Full Text] [Related]
56. Objective functional assessment of the efficacy of tenoxicam in the treatment of acute low back pain. A double-blind placebo-controlled study.
Szpalski M; Hayez JP
Br J Rheumatol; 1994 Jan; 33(1):74-8. PubMed ID: 8162464
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and tolerability of tenoxicam--an overview.
Vischer TL
Eur J Rheumatol Inflamm; 1987; 9(2):51-7. PubMed ID: 3329109
[TBL] [Abstract][Full Text] [Related]
58. A randomized, double-blind study to compare tenoxicam with sustained release indomethacin in osteoarthritic patients treated in general practice.
Hooper PA; O'Brien K; Spence S
J Int Med Res; 1989; 17(1):17-23. PubMed ID: 2651174
[TBL] [Abstract][Full Text] [Related]
59. A comparison of tenoxicam and piroxicam in a long-term clinical study in patients with osteoarthritis of hip or knee joints.
Waterworth RF; Waterworth SM; Taylor KM
Eur J Rheumatol Inflamm; 1985; 8(1):21-7. PubMed ID: 3915884
[No Abstract] [Full Text] [Related]
60. The suppression of heterotopic ossification after total hip arthroplasty.
Reis HJ; Küsswetter W; Schellinger T
Int Orthop; 1992; 16(2):140-5. PubMed ID: 1428312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
